Heart valve and myocardial tissue engineering;Tissue engineering von herzklappen und myokard

Herz

Volumn 35, Issue 5, 2010, Pages 334-341

  Cebotari, Serghei ^a   Tudorache, Igor ^a   Schilling, Tobias ^a   Haverich, Axel ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Heart valve; Myocardium; Tissue engineering

Indexed keywords

ANGIOGENESIS; BIOCOMPATIBILITY; BIOREACTOR; CARDIOMYOPATHY; CONGENITAL HEART DISEASE; ENDOTHELIUM CELL; HEART MUSCLE; HEART RIGHT VENTRICLE OUTFLOW TRACT; HEART VALVE; HEART VALVE PROSTHESIS; ISCHEMIC CARDIOMYOPATHY; MYOFIBROBLAST; REVIEW; TERATOGENICITY; THROMBOGENICITY; TISSUE ENGINEERING; TISSUE REGENERATION; VALVULAR HEART DISEASE;

ANIMALS; BIOPROSTHESIS; BIOREACTORS; CHILD; HEART DEFECTS, CONGENITAL; HEART VALVE DISEASES; HEART VALVE PROSTHESIS; HUMANS; MICROSCOPY; MICROSCOPY, ELECTRON, SCANNING; MYOCARDIAL ISCHEMIA; MYOCARDIUM; NEOVASCULARIZATION, PHYSIOLOGIC; PROSTHESIS DESIGN; SURFACE PROPERTIES; TISSUE ENGINEERING; TISSUE SCAFFOLDS;

EID: 77957798472     PISSN: 03409937     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00059-010-3355-x     Document Type: Review

References (80)

1. Elsberg CA (1899) An experimental investigation of the treatment of wounds of the heart by means of suture of the heart muscle. J Exp Med 4:479-520
2. Cohn LH, Lambert JJ, Castaneda AR, Collins JJ Jr (2009) Cardiac valve replacement with the stabilized glutaraldehyde porcine aortic valve: indications, operative results, and followup. 1975. Chest 136:e30
3. Yuan SM, Mishaly D, Shinfeld A, Raanani E (2008) Right ventricular outflow tract reconstruction: valved conduit of choice and clinical outcomes. J Cardiovasc Med (Hagerstown) 9:327-337
4. El-Hamamsy I, Clark L, Stevens LM et al (2010) Late outcomes following freestyle versus homograft aortic root replacement: results from a prospective randomized trial. J Am Coll Cardiol 55:368-376
5. Troost E, Gewillig M, Daenen W et al (2009) Behaviour of polyester grafts in adult patients with repaired coarctation of the aorta. Eur Heart J 30:1136-1141
6. Dor V, Montiglio F, Sabatier M et al (1994) Left ventricular shape changes induced by aneurysmectomy with endoventricular circular patch plasty reconstruction. Eur Heart J 15:1063-1069
7. Silver MM, Pollock J, Silver MD et al (1980) Calcification in porcine xenograft valves in children. Am J Cardiol 45:685-689
8. Schoen FJ, Levy RJ (1984) Bioprosthetic heart valve failure: pathology and pathogenesis. Cardiol Clin 2:717-739
9. Thiede A, Timm C, Bernhard A, Muller-Ruchholtz W (1978) Studies on the antigenicity of vital allogeneic valve leaflet transplants in immunogenetically controlled strain combinations. Transplantation 26:391-395
10. Human P, Zilla P (2001) Characterization of the immune response to valve bioprostheses and its role in primary tissue failure. Ann Thorac Surg 71(Suppl):S385-S388
11. Cannegieter SC, Rosendaal FR, Briet E (1994) Thromboembolic and bleeding complications in patients with mechanical heart valve prostheses. Circulation 89:635-641
12. Goppel L, Kuster J, Froer KL, Rudolph W (1974) Extent of intravasal hemolysis in artificial valve prosthesis with reference to various prosthesis designs and their functions. Verh Dtsch Ges Inn Med 80:1200-1203
13. Donnelly RJ, Rahman AN, Manohitharajah SM (1973) Chronic hemolysis following mitral valve replacement. A comparison of the frame-mounted aortic homograft and the composite seat Starr-Edwards prosthesis. Circulation 48:823-829
14. Horstkotte D, Bircks W, Loogen F (1986) Infective endocarditis of native and prosthetic valves - the case for prompt surgical intervention? A retrospective analysis of factors affecting survival. Z Kardiol 75(Suppl 2):168-182
15. Carpentier A, Lemaigre G, Robert L (1969) Biological factors affecting long-term results of valvular heterografts. J Thorac Cardiovasc Surg 58:467-483
16. Liao K, Frater RW, LaPietra A et al (1995) Time-dependent effect of glutaraldehyde on the tendency to calcify of both autografts and xenografts. Ann Thorac Surg 60(Suppl):S343-S347
17. Harken DE, Soroff HS, Taylor WJ et al (1960) Partial and complete prostheses in aortic insufficiency. J Thorac Cardiovasc Surg 40:744-762
18. Ackermann K, Balling G, Eicken A et al (2007) Replacement of the systemic atrioventricular valve with a mechanical prosthesis in children aged less than 6 years: late clinical results of survival and subsequent replacement. J Thorac Cardiovasc Surg 134:750-756
19. Beierlein W, Becker V, Yates R et al (2007) Long-term follow-up after mitral valve replacement in childhood: poor event-free survival in the young child. Eur J Cardiothorac Surg 31:860-865
20. Pai GP, Ellison RG, Rubin JW et al (1987) Disc immobilization of Bjork-Shiley and Medtronic Hall valves during and immediately after valve replacement. Ann Thorac Surg 44:73-76
21. Starek PJ (1981) Immobilization of disc heart valves by unraveled sutures. Ann Thorac Surg 31:66-69
22. Vacanti J (2010) Tissue engineering and regenerative medicine: from first principles to state of the art. J Pediatr Surg 45:291-294
23. Kodama S, Kojima K, Furuta S et al (2009) Engineering functional islets from cultured cells. Tissue Eng Part A 15:3321-3329
24. Jawad H, Ali NN, Lyon AR et al (2007) Myocardial tissue engineering: a review. J Tissue Eng Regen Med 1:327-342
25. Sacks MS, Schoen FJ, Mayer JE (2009) Bioengineering challenges for heart valve tissue engineering. Annu Rev Biomed Eng 11:289-313
26. Taylor DA (2009) From stem cells and cadaveric matrix to engineered organs. Curr Opin Biotechnol 20:598-605
27. Dado D, Levenberg S (2009) Cell-scaffold mechanical interplay within engineered tissue. Semin Cell Dev Biol 20:656-664
28. Place ES, Evans ND, Stevens MM (2009) Complexity in biomaterials for tissue engineering. Nat Mater 8:457-470
29. Tuzlakoglu K, Reis RL (2009) Biodegradable polymeric fiber structures in tissue engineering. Tissue Eng Part B Rev 15:17-27
30. Shinoka T, Breuer C (2008) Tissue-engineered blood vessels in pediatric cardiac surgery. Yale J Biol Med 81:161-166
31. Mendelson K, Schoen FJ (2006) Heart valve tissue engineering: concepts, approaches, progress, and challenges. Ann Biomed Eng 34:1799-1819
32. Brody S, Pandit A (2007) Approaches to heart valve tissue engineering scaffold design. J Biomed Mater Res B Appl Biomater 83:16-43
33. Dreger SA, Thomas P, Sachlos E et al (2006) Potential for synthesis and degradation of extracellular matrix proteins by valve interstitial cells seeded onto collagen scaffolds. Tissue Eng 12:2533-2540
34. Jockenhoevel S, Zund G, Hoerstrup SP et al (2001) Fibrin gel - advantages of a new scaffold in cardiovascular tissue engineering. Eur J Cardiothorac Surg 19:424-430
35. Tamariz E, Grinnell F (2002) Modulation of fibroblast morphology and adhesion during collagen matrix remodeling. Mol Biol Cell 13:3915-3929
36. Knight RL, Wilcox HE, Korossis SA et al (2008) The use of acellular matrices for the tissue engineering of cardiac valves. Proc Inst Mech Eng [H] 222:129-143
37. Dohmen PM, Konertz W (2009) Tissue-engineered heart valve scaffolds. Ann Thorac Cardiovasc Surg 15:362-367
38. Bader A, Schilling T, Teebken OE et al (1998) Tissue engineering of heart valves - human endothelial cell seeding of detergent acellularized porcine valves. Eur J Cardiothorac Surg 14:279-284
39. O'Brien MF, Goldstein S, Walsh S et al (1999) The SynerGraft valve: a new acellular (nonglutaraldehyde-fixed) tissue heart valve for autologous recellularization first experimental studies before clinical implantation. Semin Thorac Cardiovasc Surg 11:194-200
40. Leyh R, Wilhelmi M, Haverich A, Mertsching H (2003) A xenogeneic acellularized matrix for heart valve tissue engineering: in vivo study in a sheep model. Z Kardiol 92:938-946
41. Kasimir MT, Rieder E, Seebacher G et al (2006) Decellularization does not eliminate thrombogenicity and inflammatory stimulation in tissue-engineered porcine heart valves. J Heart Valve Dis 15:278-286; discussion 286
42. Rieder E, Seebacher G, Kasimir MT et al (2005) Tissue engineering of heart valves: decellularized porcine and human valve scaffolds differ importantly in residual potential to attract monocytic cells. Circulation 111:2792-2797
43. Cebotari S, Mertsching H, Kallenbach K et al (2002) Construction of autologous human heart valves based on an acellular allograft matrix. Circulation 106:I63-I68
44. Schmidt D, Hoerstrup SP (2006) Tissue engineered heart valves based on human cells. Swiss Med Wkly 136:618-623
45. Schnell AM, Hoerstrup SP, Zund G et al (2001) Optimal cell source for cardiovascular tissue engineering: venous vs. aortic human myofibroblasts. Thorac Cardiovasc Surg 49:221-225
46. Kim SS, Lim SH, Hong YS et al (2006) Tissue engineering of heart valves in vivo using bone marrow-derived cells. Artif Organs 30:554-557
47. Breymann C, Schmidt D, Hoerstrup SP (2006) Umbilical cord cells as a source of cardiovascular tissue engineering. Stem Cell Rev 2:87-92
48. Asahara T, Murohara T, Sullivan A et al (1997) Isolation of putative progenitor endothelial cells for angiogenesis. Science 275:964-967
49. Cebotari S, Lichtenberg A, Tudorache I et al (2006) Clinical application of tissue engineered human heart valves using autologous progenitor cells. Circulation 114:I132-137
50. Karim N, Golz K, Bader A (2006) The cardiovascular tissue-reactor: a novel device for the engineering of heart valves. Artif Organs 30:809-814
51. Lichtenberg A, Tudorache I, Cebotari S et al (2006) In vitro re-endothelialization of detergent decellularized heart valves under simulated physiological dynamic conditions. Biomaterials 27:4221-4229
52. Cebotari S, Walles T, Sorrentino S et al (2002) Guided tissue regeneration of vascular grafts in the peritoneal cavity. Circ Res 90:e71
53. Ruffer A, Purbojo A, Cicha I et al (2010) Early failure of xenogenous de-cellularised pulmonary valve conduits - a word of caution! Eur J Cardiothorac Surg 38:78-85
54. Simon P, Kasimir MT, Seebacher G et al (2003) Early failure of the tissue engineered porcine heart valve SYNERGRAFT in pediatric patients. Eur J Cardiothorac Surg 23:1002-1006; discussion 1006
55. Da Costa FD, Dohmen PM, Duarte D et al (2005) Immunological and echocardiographic evaluation of decellularized versus cryopreserved allografts during the Ross operation. Eur J Cardiothorac Surg 27:572-578
56. Hibino N, McGillicuddy E, Matsumura G et al (2010) Late-term results of tissue-engineered vascular grafts in humans. J Thorac Cardiovasc Surg 139:431-436, 436.e1-2
57. Meyer GP, Wollert KC, Lotz J et al (2009) Intracoronary bone marrow cell transfer after myocardial infarction: 5-year follow-up from the randomized-controlled BOOST trial. Eur Heart J 30:2978-2984
58. Menasche P (2008) Current status and future prospects for cell transplantation to prevent congestive heart failure. Semin Thorac Cardiovasc Surg 20:131-137
59. Murry CE, Soonpaa MH, Reinecke H et al (2004) Haematopoietic stem cells do not transdifferentiate into cardiac myocytes in myocardial infarcts. Nature 428:664-668
60. Haverich A (2008) Cardiac tissue engineering. Eur J Cardiothorac Surg 34:227-228
61. Menasche P (2008) Skeletal myoblasts and cardiac repair. J Mol Cell Cardiol 45:545-553
62. Westrich J, Yaeger P, He C et al (2010) Factors affecting residence time of mesenchymal stromal cells (MSC) injected into the myocardium. Cell Transplant [Epub ahead of print]
63. Mathiasen AB, Haack-Sorensen M, Kastrup J (2009) Mesenchymal stromal cells for cardiovascular repair: current status and future challenges. Future Cardiol 5:605-617
64. Zhang F, Pasumarthi KB (2008) Embryonic stem cell transplantation: promise and progress in the treatment of heart disease. BioDrugs 22:361-374
65. Lee AS, Tang C, Cao F et al (2009) Effects of cell number on teratoma formation by human embryonic stem cells. Cell Cycle 8:2608-2612
66. Guan K, Wagner S, Unsold B et al (2007) Generation of functional cardiomyocytes from adult mouse spermatogonial stem cells. Circ Res 100:1615-1625
67. Mauritz C, Schwanke K, Reppel M et al (2008) Generation of functional murine cardiac myocytes from induced pluripotent stem cells. Circulation 118:507-517
68. Zwi L, Caspi O, Arbel G et al (2009) Cardiomyocyte differentiation of human induced pluripotent stem cells. Circulation 120:1513-1523
69. Black LD 3rd, Meyers JD, Weinbaum JS et al (2009) Cell-induced alignment augments twitch force in fibrin gel-based engineered myocardium via gap junction modification. Tissue Eng Part A 15:3099-3108
70. Kutschka I, Chen IY, Kofidis T et al (2006) Collagen matrices enhance survival of transplanted cardiomyoblasts and contribute to functional improvement of ischemic rat hearts. Circulation 114:I167-I173
71. Brown DA, Beygui RE, MacLellan WR et al (2005) Modulation of gene expression in neonatal rat cardiomyocytes by surface modification of polylactide-co-glycolide substrates. J Biomed Mater Res A 74:419-429
72. Fromstein JD, Zandstra PW, Alperin C et al (2008) Seeding bioreactor-produced embryonic stem cell-derived cardiomyocytes on different porous, degradable, polyurethane scaffolds reveals the effect of scaffold architecture on cell morphology. Tissue Eng Part A 14:369-378
73. Jin J, Jeong SI, Shin YM et al (2009) Transplantation of mesenchymal stem cells within a poly(lactide-co-epsilon-caprolactone) scaffold improves cardiac function in a rat myocardial infarction model. Eur J Heart Fail 11:147-153
74. Park H, Radisic M, Lim JO et al (2005) A novel composite scaffold for cardiac tissue engineering. In Vitro Cell Dev Biol Anim 41:188-196
75. Shimizu T, Sekine H, Yamato M, Okano T (2009) Cell sheet-based myocardial tissue engineering: new hope for damaged heart rescue. Curr Pharm Des 15:2807-2814
76. Curtis MW, Russell B (2009) Cardiac tissue engineering. J Cardiovasc Nurs 24:87-92
77. Radisic M, Park H, Chen F et al (2006) Biomimetic approach to cardiac tissue engineering: oxygen carriers and channeled scaffolds. Tissue Eng 12:2077-2091
78. Tudorache I, Kostin S, Meyer T et al (2009) Viable vascularized autologous patch for transmural myocardial reconstruction. Eur J Cardiothorac Surg 36:306-311; discussion 311
79. Dohmen PM, Lembcke A, Holinski S et al (2007) Mid-term clinical results using a tissue-engineered pulmonary valve to reconstruct the right ventricular outflow tract during the Ross procedure. Ann Thorac Surg 84:729-736
80. Narine K, Ing EC, Cornelissen M et al (2006) Readily available porcine aortic valve matrices for use in tissue valve engineering. Is cryopreservation an option? Cryobiology 53:169-181